Inguinal Hernia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

 Inguinal Hernia Market Outlook

Thelansis’s “Inguinal Hernia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Inguinal Hernia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Inguinal Hernia Overview

A hernia is a broad term for the protrusion or bulging of an organ or tissue through an abnormal opening within the body’s structure. While hernias come in various types, they typically involve the abdomen. Roughly 75% of hernias occur in the inguinal region. The symptoms of an inguinal hernia can manifest gradually or suddenly, such as with incarceration, when the hernia sac’s contents cannot return to the abdomen. In some cases, inguinal hernias might not exhibit symptoms and could be discovered incidentally during routine physical exams. When symptoms are present, patients often experience significant groin pain, sometimes accompanied by a burning, gurgling, or aching sensation due to tissue stretching or tearing around the hernia defect. Certain factors can increase the likelihood of developing an inguinal hernia. One contributing factor is a weakened abdominal wall, which can lead to pressure causing the hernia to form. Additional risk factors encompass:

• Genetic predisposition
• Premature birth
• Cystic fibrosis
• Prior history of inguinal hernia
• Chronic constipation
• Male gender
• Obesity or overweight
• Persistent coughing
• Pregnancy

The most frequent complications from hernia repair include hematomas, bruising around the penile or scrotal area, seromas, and wound infections. Inguinal hernias are much more prevalent in males, with a 9:1 ratio, particularly among men aged 40 to 59. It’s estimated that over a quarter of adult men in the United States have a medically recognizable inguinal hernia. In women, a higher incidence of inguinal hernias has been linked to factors such as taller height, chronic cough, umbilical hernias, older age, and rural residence.

 

Geography coverage:

G8 (United States, EU5 [France, Germany, Italy, Spain, U.K.], Japan, and China)

Insights driven by robust research, including:

• In-depth interviews with leading KOLs and payers
• Physician surveys
• RWE analysis for claims and EHR datasets
• Secondary research (e.g., peer-reviewed journal articles, third-party research databases)

Deliverables format and updates*:

• Detailed Report (PDF)
• Market Forecast Model (MS Excel-based automated dashboard)
• Epidemiology (MS Excel; interactive tool)
• Executive Insights (PowerPoint presentation)
• Others: regular updates, customizations, consultant support

*As per Thelansis’s policy, we ensure that we include all the recent updates before releasing the report content and market model.

Salient features of Market Forecast model:

• 10-year market forecast (2024–2034)
• Bottom-up patient-based market forecasts validated through the top-down sales methodology
• Covers clinically and commercially-relevant patient populations/ line of therapies
• Annualized drug-level sales and patient share projections
• Utilizes our proprietary Epilansis and Analog tool (e.g., drug uptake and erosion) datasets and conjoint analysis approach
• Detailed methodology/sources & assumptions
• Graphical and tabular outputs
• Users can customize the model based on requirements

Key business questions answered:

• How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)?
• How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments?
• What is the 10-year market outlook for sales and patient share?
• Which events will have the greatest impact on the market’s trajectory?
• What insights do interviewed experts provide on current and emerging treatments?
• Which pipeline products show the most promise, and what is their potential for launch and future positioning?
• What are the key unmet needs and KOL expectations for target profiles?
• What key regulatory and payer requirements must be met to secure drug approval and favorable market access?
• and more…

Read more: Inguinal Hernia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034